Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®): Evaluation of Radiographic and Patient Outcomes

NCT00948532 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.

NCT NCT00948532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00948532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®): Evaluation of Radiographic and Patient Outcomes
Lead sponsor
NuVasive
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2012
Enrollment
104 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, degenerative disc disease